Your browser doesn't support javascript.
loading
The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy.
Szabo, Agoston Gyula; Thorsen, Jonathan; Iversen, Katrine Fladeland; Levring, Mette Bøegh; Preiss, Birgitte; Helleberg, Carsten; Breinholt, Marie Fredslund; Hermansen, Emil; Gjerdrum, Lise Mette Rahbek; Bønløkke, Søren Thorgaard; Nielsen, Katrine; Kjeldsen, Eigil; Teodorescu, Elena Manuela; Dokhi, Marveh; Kurt, Eva; Strandholdt, Casper Nørgaard; Andersen, Mette Klarskov; Vangsted, Annette Juul.
Afiliación
  • Szabo AG; Department of Hematology, Vejle Hospital, Vejle, Denmark.
  • Thorsen J; Department of Hematology Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
  • Iversen KF; COPSAC, Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Levring MB; Department of Hematology, Vejle Hospital, Vejle, Denmark.
  • Preiss B; Department of Hematology, Odense University Hospital, Odense, Denmark.
  • Helleberg C; Department of Pathology, Odense University Hospital, Odense, Denmark.
  • Breinholt MF; Department of Pathology, Herlev University Hospital, Herlev, Denmark.
  • Hermansen E; Department of Pathology, Herlev University Hospital, Herlev, Denmark.
  • Gjerdrum LMR; Department of Hematology, Zealand University Hospital, Roskilde, Denmark.
  • Bønløkke ST; Department of Pathology, Zealand University Hospital, Roskilde, Denmark.
  • Nielsen K; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Kjeldsen E; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Teodorescu EM; Department of Hematology, Aarhus University Hospital, Aarhus, Denmark.
  • Dokhi M; Department of Hematology, Aalborg University Hospital, Aalborg, Denmark.
  • Kurt E; Department of Hematology Rigshospitalet, Copenhagen University, Copenhagen, Denmark.
  • Strandholdt CN; Department of Hematology, Regionshospitalet Holstebro, Holstebro, Denmark.
  • Andersen MK; Department of Hematology, Hospital of South West Jutland, Esbjerg, Denmark.
  • Vangsted AJ; Department of Clinical Genetics, Rigshospitalet, Copenhagen, Denmark.
Am J Hematol ; 97(3): E117-E120, 2022 03 01.
Article en En | MEDLINE | ID: mdl-34967035
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Esperanza de Vida / Mieloma Múltiple Tipo de estudio: Observational_studies Límite: Female / Humans / Male Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Esperanza de Vida / Mieloma Múltiple Tipo de estudio: Observational_studies Límite: Female / Humans / Male Idioma: En Revista: Am J Hematol Año: 2022 Tipo del documento: Article País de afiliación: Dinamarca